Ads
related to: Bio Foods- Splash Refresher™
Flavored Water Beverage
With Zero Sugar. Explore Today.
- Stay In Touch
More Products. More Flavors.
Right Where You Are.
- Splash Refresher™
Search results
BlueSphere Bio's huge week with FDA approval for dosing and National Cancer Institute agreement -...
The Business Journals· 15 hours agoBlueSphere Bio, a UPMC Enterprises spinout and Pittsburgh-based drug development company, logged a big week in its development with a clearance from the U.S. Food ...
‘Today worked out beautifully’: Publix customer says she got paid to leave with $37 of food
The Daily Dot· 2 hours agoA couponer posted a viral video saying she was paid to take $37 worth of food out of the Publix...
Adicet Bio gains on FDA fast track designation for ADI-001 in lupus nephritis
Seeking Alpha· 3 days agoAdicet Bio (ACET) on Wednesday said that the U.S. Food and Drug Administration has granted Fast...
Be Bio’s haemophilia B treatment gains FDA orphan drug status
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe US Food and Drug Administration (FDA) has granted orphan drug designation to Be Biopharma’s (Be ...
Hsbc Holdings PLC Grows Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)
ETF DAILY NEWS· 5 days agoHsbc Holdings PLC lifted its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 34.3% in the fourth quarter, Holdings Channel reports ...
Adicet Bio gains FDA Fast Track for lupus nephritis treatment By Investing.com
Investing.com· 3 days agoREDWOOD CITY, Calif. & BOSTON - Adicet Bio, Inc. (NASDAQ: ACET), a biotechnology firm in the...
Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
BioPharma Dive via Yahoo Finance· 21 hours agoAfter 34 years, Geron finally has an approved medicine in Rytelo. Elsewhere, Shionogi disclosed...
The impact of fossil-based plastics in food and drinks packaging
Packaging Gateway via Yahoo Finance· 5 days agoSuch attributes align with environmental goals but also highlight the complexity of fully...
Eli Lilly Is Trading At A Record High Ahead Of A Key FDA Meeting — Is It A Buy?
Investor's Business Daily· 15 hours agoLilly is also testing Mounjaro's ability to improve morbidity and mortality in patients with obesity...
Why biotech's big convention isn't returning to San Francisco. (Hint: It has nothing to do with a...
The Business Journals· 2 days agoInstead, said BIO CEO John Crowley, BIO has contracts in San Diego, where 19,000 attendees this week...
